1. Assenov, Y., Ramírez, F., Schelhorn, S.E., Lengauer, T., & Albrecht, M. (2007). Computing topological parameters of biological networks. Bioinformatics, 24(2), 282-4. [DOI:10.1093/bioinformatics/btm554] [PMID] [
DOI:10.1093/bioinformatics/btm554]
2. Attwells, S., Setiawan, E., Wilson, A.A., Rusjan, P.M., Mizrahi, R., Miler, L., et al. (2017). Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiatry, 74(8), 833-40. [DOI:10.1001/jamapsychiatry.2017.1567] [
DOI:10.1001/jamapsychiatry.2017.1567]
3. Behl, A., Swami, G., Sircar, S., Bhatia, M., & Banerjee, B. (2010). Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology, 61(4), 210-4. [DOI:10.1159/000306591] [
DOI:10.1159/000306591]
4. Celik, G., Tas, D. A., Varmıs, D. A., Tahiroglu, A., & Avci, A. (2016). Vitamin D insufficiency in a boy with obsessive–compulsive disorder. Pediatrics International, 58(7), 646-8. [DOI:10.1111/ped.12941] [PMID] [
DOI:10.1111/ped.12941]
5. Dickerson, F., Stallings, C., Origoni, A., Vaughan, C., Khushalani, S., Yang, S., et al. (2013). C-reactive protein is elevated in schizophrenia. Schizophrenia Research, 143(1), 198-202. [DOI:10.1016/j.schres.2012.10.041] [
DOI:10.1016/j.schres.2012.10.041]
6. Esnafoğlu, E., & Yaman, E. (2017). Vitamin B12, folic acid, homocysteine and vitamin D levels in children and adolescents with obsessive compulsive disorder. Psychiatry Research, 254, 232-7. [DOI:10.1016/j.psychres.2017.04.032] [
DOI:10.1016/j.psychres.2017.04.032]
7. Fan, S., van den Heuvel, O. A., Cath, D. C., van der Werf, Y. D., De Wit, S. J., de Vries, F. E., et al. (2015). Mild white matter changes in un-medicated obsessive-compulsive disorder patients and their unaffected siblings. Frontiers in Neuroscience, 9, 495. [DOI:10.3389/fnins.2015.00495] [
DOI:10.3389/fnins.2015.00495]
8. Föcking, M., Dicker, P., Lopez, L. M., Hryniewiecka, M., Wynne, K., English, J. A., et al. (2016). Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder. Translational Psychiatry, 6(11), e959. [DOI:10.1038/tp.2016.224] [
DOI:10.1038/tp.2016.224]
9. Frye, M. A., Nassan, M., Jenkins, G., Kung, S., Veldic, M., Palmer, B., et al. (2015). Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders. Translational Psychiatry, 5(12), e689. [DOI:10.1038/tp.2015.185] [
DOI:10.1038/tp.2015.185]
10. Hasanzadeh, H., Rezaie-Tavirani, M., Seyyedi, S., Emadi, A. (2015). [Proteomics Study of extremely low frequency electromagnetic field (50 Hz) on human neuroblastoma cells (Persian)]. Koomesh, 17(1), 233-8.
11. Jaffe, A., Deep Soboslay, A., Tao, R., Hauptman, D., Kaye, W., Arango, V., et al. (2014). Genetic neuropathology of obsessive psychiatric syndromes. Translational Psychiatry, 4(9), e432. [DOI:10.1038/tp.2014.68] [
DOI:10.1038/tp.2014.68]
12. Karbalaei, R., Piran, M., Rezaei Tavirani, M., Asadzadeh Aghdaei, H., & Heidari, M. H. (2017). One systems biology analysis protein-protein interaction of NASH and IBD based on comprehensive gene information. Gastroenterology and Hepatology from Bed to Bench, 10(3), 194-201. [PMID] [PMCID] [
PMID] [
PMCID]
13. Korth, C., Bader, V., Trossbach, S., Hamburg, H., Marreiros, R., Ottis, P., et al. (2017). Functional proteomics backed by genetics and reverse genetic engineering: A novel successful approach to identify schizophrenia subsets. European Neuropsychopharmacology, 27(3), S510. [DOI:10.1016/j.euroneuro.2016.09.619] [
DOI:10.1016/j.euroneuro.2016.09.619]
14. Lohr, M., Edlund, K., Botling, J., Hammad, S., Hellwig, B., Othman, A., et al. (2013). The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. Cancer Letters, 333(2), 222-8. [DOI:10.1016/j.canlet.2013.01.036] [
DOI:10.1016/j.canlet.2013.01.036]
15. Zamanian Azodi, M., Rezaei Tavirani, M., Arefi Oskouie, A., Hamdieh, M., Derakhshan, M. K., Ahmadzadeh, A., et al. (2017). Fluoxetine regulates Ig kappa chain c region expression levels in the serum of obsessive-compulsive disorder patients: A proteomic approach. Iranian Journal of Pharmaceutical Research, 16(3), 1264-71. [PMCID] [
PMID] [
PMCID]
16. Maes, M., Delange, J., Ranjan, R., Meltzer, H. Y., Desnyder, R., Cooremans, W., et al. (1997). Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs. Psychiatry Research, 66(1),1-11. [DOI:10.1016/S0165-1781(96)02915-0] [
DOI:10.1016/S0165-1781(96)02915-0]
17. Mattheisen, M., Samuels, J. F., Wang, Y., Greenberg, B. D., Fyer, A. J., McCracken, J. T., et al. (2015). Genome-wide association study in obsessive-compulsive disorder: Results from the OCGAS. Molecular Psychiatry, 20(3), 337-44. [DOI:10.1038/mp.2014.43] [
DOI:10.1038/mp.2014.43]
18. Mendez-David, I., Boursier, C., Domergue, V., Colle, R., Falissard, B., Corruble, E., et al. (2017). Differential peripheral proteomic biosignature of fluoxetine response in a mouse model of anxiety/depression. Frontiers in Cellular Neuroscience, 11, 237. [DOI:10.3389/fncel.2017.00237] [
DOI:10.3389/fncel.2017.00237]
19. Petrov, B.R. (2017). A new role for vitamin D binding protein in bipolar disorder [MSc. thesis]. Columbus, Ohio: The Ohio State University.
20. Rasmussen, L. J. H., Schultz, M., Gaardsting, A., Ladelund, S., Garred, P., Iversen, K., et al. (2017). Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer. Radiation Oncology Investigations, 141(1), 191-9. [DOI:10.1002/ijc.30732] [
DOI:10.1002/ijc.30732]
21. Safaei, A., Tavirani, M. R., Azodi, M. Z, Lashay, A., Mohammadi, S. F., Broumand, M. G., et al. (2017). Diabetic retinopathy and laser therapy in rats: A protein-protein interaction network analysis. Journal of Lasers in Medical Sciences, 8(3), 20-1. [DOI:10.15171/jlms.2017.s4] [
DOI:10.15171/jlms.2017.s4]
22. Sarokhani, D., Sarokhani, M., Sayehmiri, K., & Azodi, M. Z. (2016). The evaluation of obsessive-compulsive disorder prevalence in iran: a meta-analysis and systematic review. International Journal of Pharmacy & Technology, 8(4), 21482-92.
23. Seal, U. S., Eist, H. (1996). Elevation of serum protein-bound carbohydrates and haptoglobin in schizophrenia. Clinical Chemistry, 12(10), 709-16.
24. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., et al. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498-504. [DOI:10.1101/gr.1239303] [PMID] [PMCID] [
DOI:10.1101/gr.1239303]
25. Sherman, B. T., & Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4(1), 44-57. [DOI:10.1038/nprot.2008.211] [
DOI:10.1038/nprot.2008.211]
26. Shrivastava, A., Kar, S. K., Sharma, E., Mahdi, A. A., & Dalal, P. K. (2017). A study of oxidative stress biomarkers in obsessive compulsive disorder. Journal of Obsessive-Compulsive and Related Disorders, 15, 52-6.[DOI:10.1016/j.jocrd.2017.09.004] [
DOI:10.1016/j.jocrd.2017.09.004]
27. Sinopoli, V., Burton, C. L., Kronenberg, S., & Arnold, P. D. (2017). A review of the role of serotonin system genes in obsessive-compulsive disorder. Neuroscience & Biobehavioral Reviews, 80, 372-81. [DOI:10.1016/j.neubiorev.2017.05.029] [PMID] [
DOI:10.1016/j.neubiorev.2017.05.029]
28. Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., et al. (2017). The STRING database in 2017: Quality-controlled protein–protein association networks, made broadly accessible. Nucleic Acids Research, 45(D1), D362-D8. [DOI:10.1093/nar/gkw937] [
DOI:10.1093/nar/gkw937]
29. Tang, H. Y., Beer, L. A., & Speicher, D. W. (2011). In-depth analysis of a plasma or serum proteome using a 4D protein profiling method. Methods in Molecular Biology, 728, 47-67. [DOI:10.1007/978-1-61779-068-3_3] [PMID] [PMCID] [
DOI:10.1007/978-1-61779-068-3_3]
30. Taylor, S. (2013). Molecular genetics of obsessive–compulsive disorder: A comprehensive meta-analysis of genetic association studies. Molecular Psychiatry, 18(7), 799-805. [DOI:10.1038/mp.2012.76] [
DOI:10.1038/mp.2012.76]
31. Tolosano, E., & Altruda, F. (2002). Hemopexin: Structure, function, and regulation. DNA and Cell Biology, 21(4), 297-306. [DOI:10.1089/104454902753759717] [PMID] [
DOI:10.1089/104454902753759717]
32. Tseng, C. F., Lin, C. C., Huang, H. Y., Liu, H. C., & Mao, S. J. (2004). Antioxidant role of human haptoglobin. Proteomics, 4(8), 2221-8. [DOI:10.1002/pmic.200300787] [PMID] [
DOI:10.1002/pmic.200300787]
33. Zamanian Azodi, M., Rezaei Tavirani, M., Kermani Ranjbar, T., Arefi Oskouie, A., Rezaei Tavirani, M., Rahmati Rad, S., et al. (2015). [Pathophysiology, genetics, types, and treatments in obsessive compulsive disorder (Persian)]. Koomesh, 16(4), 475-87.
34. Zamanian Azodi, M., Rezaei Tavirani, M., Nejadi, N., Arefi Oskouie, A., Zayeri, F., Hamdieh, M., et al. (2017). Serum proteomic profiling of obsessive-compulsive disorder, washing subtype: A preliminary study. Basic and Clinical Neuroscience, 8(4), 307-16. [DOI:10.18869/nirp.bcn.8.4.307] [
DOI:10.18869/nirp.bcn.8.4.307]